CCL2 and COVID-19: Several inflammatory CCs and notably MCP1, IP10, IL6, IL1Ra, IL10 and TNFa had more associations (Fig. 1D, COVID-19) with the BIMs suggesting that these CCs are the inflammatory markers driving brain injury.